China's Inspectorate Begins Enforcing New Drug GMPs Overseas
This article was originally published in PharmAsia News
Inspections are part of a bid to raise domestic quality to global standards
You may also be interested in...
SHANGHAI - Multinational pharma companies need to review their manufacturing practices to ensure full compliance with China's new GMP regulations, which went into effect March 1
Alkermes CRL is just the latest fallout from black-hole process.
Letter of authorization for COVID-19 therapeutic made at troubled Lilly plant requires independent third-party oversight.